<DOC>
	<DOCNO>NCT01597765</DOCNO>
	<brief_summary>The purpose study determine efficacy antioxidant cocktail alleviation oxidative stress iron overload beta-thalassemia/Hb E patient .</brief_summary>
	<brief_title>Effect Antioxidant Cocktail Beta-thalassemia/Hb E Patients</brief_title>
	<detailed_description>60 case beta-thalassemia/Hb E patient . All patient diagnose hemoglobin type beta-thalassemia/Hb E disease receive blood transfusion treatment least 3 month prior study . The study randomize control trial design treatment antioxidant cocktail . The antioxidant cocktail consist vitamin E 400 IU/day , curcuminoids 500 mg/day , N-acetylcysteine 200 mg/day deferiprone 50 mg/kg/day . All patient receive antioxidant cocktail daily 12 month . The patient regularly follow analyzed biochemical parameter every two month treatment withdrawal 3 month .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1. age 1850 year 2. hemoglobin level 69 g/dL screen visit 3. WHO performance status grade 02 4. sign inform consent prior study entry . 1. receive iron chelator blood transfusion . 2. pregnancy breastfeed 3. receive drug except folic acid least 30 day study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>antioxidant cocktail</keyword>
</DOC>